Edwards Wildman Palmer LLP
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
AbbVie Inc. Enanta Pharmaceuticals, Inc.
A C
A61P C07D
inventional inventional
Yat Sun Keith F. Timothy David J. Todd Jason P. Brian Hui-Ju
Or McDaniel Middleton Grampovnik Hopkins Shanley Green Chen